MedTrace Logo

Daily vs. Non-Daily SBRT for NSCLC

NCT03624907 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-10-04

No results posted yet for this study

Summary

The purpose of this study is to determine if stereotactic body radiotherapy (SBRT) on non-consecutive days will increase the chances of curing non-small cell lung cancer when compared to daily treatment.

Conditions

Interventions

RADIATION

Daily Stereotactic Body Radiotherapy

After randomization, participants will receive daily standard of care doses of radiotherapy at treating physicians discretion.

RADIATION

Non-Daily Stereotactic Body Radiotherapy

After randomization, participants will receive non-daily standard of care doses of radiotherapy at treating physicians discretion.

Sponsors & Collaborators

  • DiaCarta, Inc.

    collaborator INDUSTRY

  • University of Florida

    lead OTHER

Principal Investigators

  • Anamaria Yeung, MD · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-19
Primary Completion
2021-06-16
Completion
2021-06-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03624907 on ClinicalTrials.gov